Ganoderic acid Y

• CAT Number: I017403
• CAS Number: 86377-52-8
• Molecular Formula: C₃₀H₄₆O₃
• Molecular Weight: 454.68
• Purity: ≥95%
• Target: Anti-infection
• IUPAC Name: (E,6R)-6-[(3S,5R,10S,13R,14R,17R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid
• InChI: InChI=1S/C30H46O3/c1-19(9-8-10-20(2)26(32)33)21-13-17-30(7)23-11-12-24-27(3,4)25(31)15-16-28(24,5)22(23)14-18-29(21,30)6/h10-11,14,19,21,24-25,31H,8-9,12-13,15-18H2,1-7H3,(H,32,33)/b20-10+/t19-,21-,24+,25+,28-,29-,30+/m1/s1
• InChIKey: HUTCYUJPLOTDMX-SPPZYOJVSA-N
• SMILES: C[C@H](CC/C=C(\C)/C(=O)O)[C@H]1CC[C@@]2([C@@]1(CC=C3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C

Ganoderic Acid Y（Cat No.:I017403）is a high-purity triterpenoid derived from Ganoderma lucidum (Reishi mushroom), widely recognized for its diverse pharmacological properties. It exhibits potent anti-inflammatory, anticancer, and antioxidant activities, making it valuable for natural product and biomedical research. Ganoderic Acid Y is extensively studied for its ability to modulate signaling pathways, inhibit tumor growth, and protect against oxidative stress. This bioactive compound is instrumental in exploring therapeutic strategies for cancer, inflammation, and age-related disorders. Its high purity ensures reliability in experimental and preclinical research settings.